Abstract:The growth & proliferation of cancer cells is fundamentally dependent on metabolic processes, and tumours frequently display altered metabolism compared with healthy tissues. To sustain enhanced growth, and to resist stresses associated with cancer treatments, cancer cells become highly dependent on the uptake of exogenous nutrients, particularly amino acids. Amino acid metabolism supports tumour growth and survival in numerous ways, particularly in the provision of anabolic precursors for macromolecule (e.g. protein and DNA) synthesis, as well as stress responsive antioxidant pathways (e.g. glutathione/GSH synthesis). We have shown that uptake of exogenous serine and glycine is key nutrient dependency for many cancer cells, simultaneously supporting THF-dependent one carbon metabolism and GSH synthesis. More recently we have defined a role for immune-regulated IDO1 dependent tryptophan metabolism as an alternative one-carbon source for nucleotide synthesis, underlining the potential flexibility of tumour metabolism. The sensitivity of certain cancer cells to cysteine starvation is well established, and multiple mechanisms contribute to cysteine withdrawal sensitivity, including transsulfuration activity and methylation reactions. We have recently defined a role for methionine driven polyamine metabolism in sensitising cells to cysteine starvation, particularly in the context of MTAP gene deletion. Improved understanding of cancer specific amino acid metabolism is defining genetically driven metabolic vulnerabilities that can be therapeutically exploited by a combination of diet and small molecules. Citation Format: Oliver Maddocks. Cancer specific amino acid metabolism [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr SY41-03.

Methionine Metabolism in Health and Cancer: a Nexus of Diet and Precision Medicine

Dietary Methionine Influences Therapy in Mouse Cancer Models and Alters Human Metabolism

The methionine cycle and its cancer implications

Dietary methionine restriction targets one carbon metabolism in humans and produces broad therapeutic responses in cancer

Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine

Methionine Metabolism – A Gateway to Oral Cancer Epigenetics

Targeting methionine metabolism in cancer: opportunities and challenges

Delineating a Role for Methionine Metabolism in Colorectal Cancer

Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

DNA Methylation, Cancer Susceptibility, and Nutrient Interactions

Methylomics and cancer: the current state of methylation profiling and marker development for clinical care

A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future

The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity

Dietary methionine restriction impairs anti-tumor immunity through gut microbiota

DNA Methylation: From Cancer Biology to Clinical Perspectives

Dietary methionine restriction in cancer development and antitumor immunity

Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts

Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer

Abstract SY41-03: Cancer specific amino acid metabolism

Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy

An Epigenetic Role of Mitochondria in Cancer